106 related articles for article (PubMed ID: 8081715)
21. Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-a]pyridine adenosine A1 receptor antagonist.
Kuroda S; Akahane A; Itani H; Nishimura S; Durkin K; Kinoshita T; Tenda Y; Sakane K
Bioorg Med Chem Lett; 1999 Jul; 9(14):1979-84. PubMed ID: 10450966
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological data of 4-amino-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl esters, a new series of A1-adenosine receptor (A1AR) ligands.
Schenone S; Bruno O; Fossa P; Ranise A; Menozzi G; Mosti L; Bondavalli F; Martini C; Trincavelli L
Bioorg Med Chem Lett; 2001 Sep; 11(18):2529-31. PubMed ID: 11549462
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationship studies of novel pyrazolo[1,5-c][1,3]benzoxazines: synthesis and benzodiazepine receptor affinity.
Varano F; Catarzi D; Colotta V; Cecchi L; Filacchioni G; Galli A; Costagli C
Arch Pharm (Weinheim); 1996 Dec; 329(12):529-34. PubMed ID: 9038420
[TBL] [Abstract][Full Text] [Related]
24. Pyrazolopyridine derivatives act as competitive antagonists of brain adenosine A1 receptors: [35S]GTPgammaS binding studies.
Ito H; Maemoto T; Akahane A; Butcher SP; Olverman HJ; Finlayson K
Eur J Pharmacol; 1999 Jan; 365(2-3):309-15. PubMed ID: 9988116
[TBL] [Abstract][Full Text] [Related]
25. Effects of substituent size upon adenosine receptor A1/A2 affinity of some newly synthesised 8-cycloalkyl xanthines.
Castagnino E; Salvatori A; Corsano S; Tacchi P; Martini C; Lucacchini A
Drug Des Discov; 1995 Apr; 12(4):313-21. PubMed ID: 9040991
[TBL] [Abstract][Full Text] [Related]
26. N(6)-substituted 2-phenyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. A comparison with 2-N-butyl analogous derivatives. V.
Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A; Martini C; Tacchi P
Farmaco; 1994 Mar; 49(3):187-91. PubMed ID: 8043170
[TBL] [Abstract][Full Text] [Related]
27. Tricyclic heteroaromatic systems: synthesis, [3H]flunitrazepam brain membrane binding inhibition, and structure-activity relationships of 2,3-dihydro-2-aryl-4-R-[1]benzopyrano[4,3-c]pyrazole-3-ones.
Colotta V; Cecchi L; Melani F; Palazzino G; Filacchioni G; Martini C; Giannaccini G; Lucacchini A
J Pharm Sci; 1989 Mar; 78(3):239-42. PubMed ID: 2542524
[TBL] [Abstract][Full Text] [Related]
28. N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor.
Thompson RD; Secunda S; Daly JW; Olsson RA
J Med Chem; 1991 Sep; 34(9):2877-82. PubMed ID: 1895305
[TBL] [Abstract][Full Text] [Related]
29. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
Müller CE; Hide I; Daly JW; Rothenhäusler K; Eger K
J Med Chem; 1990 Oct; 33(10):2822-8. PubMed ID: 2213835
[TBL] [Abstract][Full Text] [Related]
30. New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
Colotta V; Catarzi D; Varano F; Capelli F; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Pedata F; Schiesaro A; Morizzo E; Moro S
J Med Chem; 2007 Aug; 50(17):4061-74. PubMed ID: 17665891
[TBL] [Abstract][Full Text] [Related]
31. Modification of A1 and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat.
Cunha RA; Constantino MC; Sebastião AM; Ribeiro JA
Neuroreport; 1995 Jul; 6(11):1583-8. PubMed ID: 7579154
[TBL] [Abstract][Full Text] [Related]
32. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA
J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407
[TBL] [Abstract][Full Text] [Related]
33. 2-substituted thioadenine nucleoside and nucleotide analogues: synthesis and receptor subtype binding affinities (1).
Hasan A; Hussain T; Mustafa SJ; Srivastava PC
Bioconjug Chem; 1994; 5(4):364-9. PubMed ID: 7948104
[TBL] [Abstract][Full Text] [Related]
34. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
35. The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives.
Federico S; Redenti S; Sturlese M; Ciancetta A; Kachler S; Klotz KN; Cacciari B; Moro S; Spalluto G
PLoS One; 2015; 10(12):e0143504. PubMed ID: 26625265
[TBL] [Abstract][Full Text] [Related]
36. A novel non-xanthine adenosine A1 receptor antagonist.
Terai T; Kita Y; Kusunoki T; Shimazaki T; Ando T; Horiai H; Akahane A; Shiokawa Y; Yoshida K
Eur J Pharmacol; 1995 Jun; 279(2-3):217-25. PubMed ID: 7556404
[TBL] [Abstract][Full Text] [Related]
37. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.
van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; Ijzerman AP
J Med Chem; 1998 Oct; 41(21):3994-4000. PubMed ID: 9767637
[TBL] [Abstract][Full Text] [Related]
38. N(6)-substituted 2-N-butyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. IV.
Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A; Martini C; Tacchi P
Farmaco; 1994 Mar; 49(3):183-6. PubMed ID: 8043169
[No Abstract] [Full Text] [Related]
39. Role of histidine residues in the adenosine A2a receptor ligand binding site.
Askalan R; Richardson PJ
J Neurochem; 1994 Oct; 63(4):1477-84. PubMed ID: 7931300
[TBL] [Abstract][Full Text] [Related]
40. Theoretical structure-activity studies of adenosine A1 ligands: requirements for receptor affinity.
Dooley MJ; Kono M; Suzuki F
Bioorg Med Chem; 1996 Jun; 4(6):923-34. PubMed ID: 8818243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
